Journal of Oncology Translational Research

ISSN: 2476-2261

Open Access

Citations Report

Journal of Oncology Translational Research : Citations & Metrics Report

Articles published in Journal of Oncology Translational Research have been cited by esteemed scholars and scientists all around the world.

Journal of Oncology Translational Research has got h-index 4, which means every article in Journal of Oncology Translational Research has got 4 average citations.

Following are the list of articles that have cited the articles published in Journal of Oncology Translational Research.

  2022 2021 2020 2019 2018

Year wise published articles

30 32 46 9 9

Year wise citations received

13 12 15 7 5
Journal total citations count 93
Journal impact factor 0.17
Journal 5 years impact factor 0.46
Journal h-index 4
Journal h-index since 2018 3
Important citations

Majumder D, Das M (2016) An analytical approach for leukemia diagnosis from light microscopic images of Rbcs (Computational approach for leukemia diagnosis). 2nd International Conference on Next Generation Computing Technologies.

Alimohamadi H, Smith AS, Fowler VM, Rangamani P (2019) Non-uniform distribution of myosin-mediated forces governs red blood cell curvature through tension modulation. bioRxiv 1: 668582

Majumder D, Das M (2019) Digital Image Analysis for Early Diagnosis of Cancer: Identification of Pre-Cancerous State. Histopathological Image Analysis in Medical Decision Making.

Indranil C (2016) Common Denominator in Liver Disease: A communication report; Focus on Reversing the Scarring that’s Common to Liver Diseases. Journal of Medical and Health Sciences.

Chen D (2017) The newest medicine: Chimeric antigen receptor T-Cell immunotherapy (CAR-T). J Transl Res 1: 1-2.

Indranil C. Journal of Medical and Health Sciences.

Chen D (2018) Dual targeting autoimmunity and cancer: From biology to medicine. The Journal of Clinical Pharmacology 58: 990-996.

Russi S, Verma HK, Laurino S, Mazzone P, Storto G, et al. (2019) Adapting and surviving: intra and extra-cellular remodeling in drug-resistant gastric cancer cells. International journal of molecular sciences 20: 3736.

Chen D (2019) Dually Efficacious Medicine Against Fibrosis and Cancer. Medical Sciences 7: 41.

Chen D, Zhang X (2017) Cellular immunity augmentation in mainstream oncologic therapy. Cancer biology & medicine 14: 121-128.

Dhar PK, Naskar TK, Majumder D (2017) An Analytical Approach for the Determination of Chemotherapeutic Drug Application Trade-Offs in Leukemia. International Conference on Next Generation Computing Technologies : 390-404.

Dhar PK, Naskar TK, Majumder D (2017) Predictive model for stem cell transplantation with suicidal gene construct for the treatment of leukemia: Analytical model for gene therapy of leukemia. Int Conf Int Com Comp Tech :194-199.

Dhar PK, Naskar TK, Majumder D. (2018) Prediction of Drug Application Optimization Based on RBC Dynamics in Maintenance Chemotherapy of Acute Lymphoblastic Leukemia Maintenance. Int Confe Bio Sys Bio : 1-5.

Kamini J (2017) Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett 3: 112.

Anitha SS, Prudhvi RP (2017) Incidence and Prevalence of Breast Cancer in USA. Biochem Mol Biol Lett 2: 102.

 Li Z, Gong X, Zhang W, Zhang J, Ding L, et al. (2019) Inhibition of miRNA‑34a promotes triple negative cancer cell proliferation by promoting glucose uptake. Experimental and Therapeutic Medicine 18: 3936-3942.

Lee JO, Kang MJ, Byun WS, Kim SA, Seo IH, et al. (2019) Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51. Breast Cancer Research 21: 1-8.

Varghese S, Samuel S, Varghese E, Kubatka P, Büsselberg D (2019) High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells. Biomolecules 9: 16.

Zhu S, Wei L, Lin G, Tong Y, Zhang J et al. (2019) Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition. Nutrition and cancer 26: 1-2.

Yin X, Wei Z, Song C, Tang C, Xu W, et al. (2018) Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal. Cancer management and research 10: 5785.

arrow_upward arrow_upward